Turku, Finland · Founded 2017 · Privately Held (backing)
Developer of a non-invasive health screening and monitoring system designed for early detection of various diseases, particularly urinary tract cancers, starting from prostate cancers. AQ Biotech is based in Turku, Finland and was founded in 2017. Its last reported valuation was $11.5 million in Apr 2025. It has raised $8.6 million.
Last reported valuation
$11.5M
Oct 2026
Priced at
—
Total raised
$8.6M
Last round
—
Cap table — not yet on record
AQ Biotech's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AQ Biotech with a free account
·Watch AQ Biotech: the Monday email on marks, rounds and moves
